2020 has been a challenging year for investors so far. As a result of the coronavirus (Covid-19) outbreak, global economic activity has slumped. This has sent shockwaves through financial markets, with many stocks experiencing double-digit declines. One area of the market that has outperformed, however, is pharmaceutical stocks. Across this sector, share prices have generally held up very well over the last few months. In
some cases, they’ve even soared. It’s not hard to understand why pharmaceutical stocks have outperformed recently. Ultimately, it’s the
pharmaceutical sector that is leading the fight against Covid-19.
Throughout the industry, scientists are working overtime to understand the deadly disease, and striving to develop vaccines and treatments
that could help save lives. Any company that can successfully develop and commercialise such a product in the near future is likely to thrive.
Of course, there are many challenges associated with vaccine and drug developments. Vaccines can take months or even years to develop. Failure rates in clinical drug trials are very high. No-one knows whether a vaccine or treatment for Covid-19 will be found any time soon. However, the progress that some of the world’s major pharmaceutical companies have made in a short period of time is certainly